Position in LLY
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$66,592,359
+$16,801,530 QoQ
Shares Held
55,520
+2.6% QoQ
Ownership
0.006%
of shares outstanding
% of Portfolio
0.93%
of 13F equity value
Holder Rank
#477
of 4,622 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 99%
Shared 0%
None 1%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Madison Asset Management, LLC holds $138,988,503 across 8 Drug Manufacturers - General names. LLY ranks #1 (47.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
This page
|
55,520 | $66,592,359 | |
| 2 | JNJ |
Johnson & Johnson
|
136,792 | $34,741,064 | |
| 3 | ABBV |
AbbVie Inc.
|
79,651 | $20,043,377 | |
| 4 | PFE |
Pfizer Inc
|
242,132 | $5,830,538 | |
| 5 | AMGN |
Amgen Inc
|
11,539 | $4,178,502 | |
| 6 | AZN |
Astrazeneca PLC
|
21,310 | $4,040,802 | |
| 7 | MRK |
Merck & Co., Inc.
|
23,786 | $3,056,501 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
4,000 | $505,360 |
All Filings in LLY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $66,592,359 | 55,520 | Shares | Sole | 2026-08-10 | |
| 2026-03-31 | $49,790,829 | 54,134 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $65,463,063 | 60,914 | Shares | Sole | 2026-02-04 | |
| 2025-09-30 | $44,907,128 | 58,856 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $43,410,466 | 55,688 | Shares | Sole | 2025-08-11 | |
| 2025-03-31 | $40,878,415 | 49,495 | Shares | Sole | 2025-05-06 | |
| 2024-12-31 | $38,328,256 | 49,648 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $44,320,034 | 50,026 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $45,861,118 | 50,654 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $39,664,290 | 50,985 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $29,709,683 | 50,967 | Shares | Sole | 2024-02-12 | |
| 2023-09-30 | $28,145,074 | 52,399 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $25,045,876 | 53,405 | Shares | Sole | 2023-08-01 | |
| 2023-03-31 | $18,825,597 | 54,818 | Shares | Sole | 2023-04-26 | |
| 2022-12-31 | $32,850,236 | 89,794 | Shares | Sole | 2023-02-08 | |
| 2022-09-30 | $28,902,963 | 89,386 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $28,654,474 | 88,377 | Shares | Sole | 2022-08-09 | |
| 2022-03-31 | $18,391,254 | 64,222 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $16,620,433 | 60,171 | Shares | Sole | 2022-02-15 | |
| 2021-09-30 | $14,291,828 | 61,856 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $13,936,454 | 60,720 | Shares | Sole | 2021-08-09 | |
| 2021-03-31 | $10,765,876 | 57,627 | Shares | Sole | 2021-05-11 | |
| 2020-12-31 | $9,541,992 | 56,515 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $7,578,624 | 51,200 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $8,267,283 | 50,355 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $6,784,379 | 48,907 | Shares | Sole | 2020-05-12 | |
| No filing history on record for this holder in this stock. | ||||||